| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.5 |